Search This Blog

Wednesday, August 7, 2019

Regenxbio EPS beats by $0.71, beats on revenue

Regenxbio (NASDAQ:RGNX): Q2 GAAP EPS of -$0.04 beats by $0.71.
Revenue of $7.88M (-80.4% Y/Y) beats by $2.43M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)